Capas, Nito A.
HRN: 21-74-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
CLINDAMYCIN 300MG (CAP)
08/10/2022
08/17/2022
PO
300mg
QID
Post-op
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes